Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Dow
AstraZeneca
Colorcon
Boehringer Ingelheim
Merck
Johnson and Johnson
Cipla
Novartis
UBS

Generated: August 23, 2017

DrugPatentWatch Database Preview

NEBUPENT Drug Profile

« Back to Dashboard

What is the patent landscape for Nebupent, and what generic Nebupent alternatives are available?

Nebupent is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in NEBUPENT is pentamidine isethionate. There are thirteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pentamidine isethionate profile page.

Summary for Tradename: NEBUPENT

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list112
Clinical Trials: see list1
Patent Applications: see list795
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NEBUPENT at DailyMed

Pharmacology for Tradename: NEBUPENT

Drug ClassAntiprotozoal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
NEBUPENT
pentamidine isethionate
FOR SOLUTION;INHALATION019887-001Jun 15, 1989RXYesYes► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
NEBUPENT
pentamidine isethionate
FOR SOLUTION;INHALATION019887-002Mar 22, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Fish and Richardson
Julphar
Daiichi Sankyo
Cantor Fitzgerald
Merck
Boehringer Ingelheim
Colorcon
Accenture
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot